Successful Pregnancy in Chronic Obstructive Pulmonary Hypertension Secondary to Pulmonary and Cardiac Hydatid Cysts: A Case Report.

Authors

Farnaz Ahmadi, Raha Parnia, Bahamin Astani, Mohammad-Sadegh Keshmiri, Shakiba Khodadad, Hakimeh Sheikhzadeh, Zahra Daneshmandi, Faezeh Ansari, Mahsa Riahi, Sima Noorali, Hannaneh Yousefi-Koma, Babak Sharif-Kashani, Shadi Shafaghi

Published in

Research in heart yield and translational medicine. Volume 21. Issue 1. Pages 111-115.

Abstract

Pregnancy is typically contraindicated in women with pulmonary hypertension (PH) due to severe mortality risks.A 31-year-old woman with PH, secondary to previous hydatid cysts, conceived against medical advice while on medical therapy. She successfully delivered via emergency C-section at 37 weeks.Her case highlights those high-risk pregnancies complicated by PH can be successfully managed through prompt, multidisciplinary care at a specialized tertiary center.
Pregnancy in women with pulmonary hypertension (PH) is contraindicated because of high mortality rates associated with physiological changes, particularly in the peripartum and postpartum periods. Termination is recommended early if pregnancy occurs. Consequently, clinical experience with continued pregnancy in patients with PH is scarce.
A 31-year-old woman was diagnosed with multiple bilateral pulmonary and right ventricular hydatid cysts. After surgical and pharmacologic treatments, she developed PH due to pulmonary artery obstruction 8 years later. Because of her condition, she was ineligible for surgery and received medical therapy, including tadalafil, bosentan, and eplerenone. After 3 years, she conceived despite advice to avoid pregnancy. At 37 weeks' gestation, she underwent successful emergency cesarean delivery because of maternal dyspnea and tachycardia.
Prompt treatment and regular follow-up in a tertiary care center using a multidisciplinary approach are crucial for managing pregnant patients with PH.

PMID:
42800990
Bibliographic data and abstract were imported from PubMed on 27 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.